Previous 10 | Next 10 |
MENLO PARK, Calif., July 27, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced that it will release financial results for the second quarter af...
Baker Brothers’ 13F portfolio value decreased from $26.54B to $23.07B this quarter. The large stake in Alexion Pharmaceuticals was decreased during the quarter. The top three positions are Seagen, BeiGene, and Incyte Corporation and they add up to almost ~57% of the portfol...
Talis Biomedical Corporation (TLIS) Q1 2021 Earnings Conference Call May 11, 2021, 04:30 PM ET Company Participants Emily Fawcett - SVP Corporate Communications and IR Brian Coe - CEO Roger Moody - CFO Conference Call Participants Tycho Peterson - JP Morgan Ivy Ma - Bank of America Merrill Ly...
Talis Biomedical (TLIS): Q1 EPS of -$4.61 may not be comparable to consensus of -$0.78.Revenue of $7M beats by $1.62M.Press Release For further details see: Talis Biomedical EPS of -$4.61
MENLO PARK, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today reported financial results and business progress for the first quarte...
MENLO PARK, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced that it will release financial results for the first quarter afte...
MENLO PARK, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (“TLIS”), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced that the company will be participating in the Bof...
Point Roberts, WA and Delta, BC - April 16, 2021 (Investorideas.com Newswire) Investorideas.com , a global news source and leading retail investor and trader resource, announces its weekly roundup of stocks to watch in Biotech, Tech, Mining and Real Estate. Today's stocks have been adde...
Gainers: Wilhelmina International (WHLM) +25%.Kaleido Biosciences (KLDO) +14%.Ardelyx (ARDX) +14%.PLBY Group (PLBY) +14%.Talis Biomedical (TLIS) +14%.Wah Fu Education (WAFU) +12%.Seelos Therapeutics (SEEL) +11%Inpixon (INPX) +11%.BCTG Acquisition (BCTG) +10%.Ballantyne Strong (...
MENLO PARK, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced the appointment of Jeryl “Jeri” Hillema...
News, Short Squeeze, Breakout and More Instantly...
Talis Biomedical Corporation Company Name:
TLIS Stock Symbol:
NASDAQ Market:
Talis Biomedical Corporation Website:
2024-07-14 22:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-24 12:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...